JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Independent Research Firm Names Engagio a Strong Performer for Account Based Marketing (ABM) Platforms
-
DBV Technologies to Attend Upcoming Investor Conferences
-
DBV Technologies to Attend Upcoming Investor Conferences
-
Ultragenyx to Present at Upcoming Investor Conferences
-
Ultragenyx to Present at Upcoming Investor Conferences
-
EverQuote Files Registration Statement for Proposed Initial Public Offering of Class A Common Stock
-
JMP Securities Starts Evelo Biosciences Inc (EVLO) at Market Outperform
-
Palo Alto Networks (PANW) PT Raised to $240 at JMP Securities
-
Loxo Oncology (LOXO) PT Raised to $221 at JMP Securities; 'LOXO-292 Data at ASCO Exceeds Expectations'
-
Blueprint Medicines (BPMC) PT Lowered to $103 at JMP Securities
-
Ares Capital (ARCC) PT Raised to $18.50 at JMP Securities
-
Vanda Pharmaceuticals Announces Participation at June 2018 Investor Conferences
-
Domo, Inc. Files Registration Statement for Proposed Initial Public Offering
-
Domo, Inc. Files Registration Statement for Proposed Initial Public Offering
-
Neos Therapeutics to Participate in Two June Conferences
-
Xencor to Present at Upcoming Investor Conferences
-
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
-
Madrigal Pharmaceuticals (MDGL) PT Raised to $300 at JMP Securities
-
Neuronetics, Inc., Maker of NeuroStar® Advanced Therapy, Announces Filing of Registration Statement for Proposed Initial Public Offering
-
Neuronetics Files $86M IPO; Plans to List Under Symbol 'STIM'
-
Bovie Medical Corporation to Participate in the JMP Securities 2018 Life Science Conference
-
Evelo Biosciences Reports First Quarter 2018 Financial Results and Recent Business Highlights
-
Evelo Biosciences Reports First Quarter 2018 Financial Results and Recent Business Highlights
-
Cherry Hill Mortgage Investment (CHMI) Prices 2.75M Share Offering for Expected Gross Proceeds of $49.6M
-
Cherry Hill Mortgage Investment Corporation Announces Pricing of Public Offering of Common Stock
-
Karyopharm to Participate in Upcoming Investor Conferences
-
Realm Therapeutics to Present at June Investor Conferences
-
Axovant to Present at Two Upcoming Investor Conferences
-
Karyopharm to Participate in Upcoming Investor Conferences
-
Box, Inc. (BOX) PT Raised to $28 at JMP Securities; 'Impressive Big Deal Metrics'
-
RealPage Announces Closing of Follow-on Public Offering of Common Stock
-
Cherry Hill Mortgage Investment (CHMI) Announces 2.75M Common Share Offering
-
Cherry Hill Mortgage Investment Corporation Announces Public Offering of Common Stock
-
ChemoCentryx to Present at Two Upcoming Investor Conferences
-
ChemoCentryx to Present at Two Upcoming Investor Conferences
-
Syros to Present at Upcoming Investor Conferences
-
Marinus Pharmaceuticals to Present at Upcoming Investor Conferences
-
Arrowhead Pharmaceuticals to Present at Upcoming June 2018 Conferences
-
Syndax Pharmaceuticals Announces Participation at Two Upcoming Investor Conferences
-
Exantas Capital Corp. (XAN) PT Raised to $11.50 at JMP Securities
-
Evolus (EOLS) PT Raised to $30 at JMP Securities; 'Hires Second C-Suite Executive from a Major Competitor'
-
AGNC Investment Corp. Announces Closing of Public Offering of Common Stock
-
Kiniksa Pharmaceuticals, Ltd. Announces Closing of Initial Public Offering
-
Halozyme Therapeutics To Participate In Upcoming Healthcare Conferences
-
Sol-Gel Technologies Announces Participation in Upcoming Investor Conferences
-
Sol-Gel Technologies Announces Participation in Upcoming Investor Conferences
-
Splunk (SPLK) PT Raised to $120 at JMP Securities; 'Impressive Big Deal and Cash Flow Metrics'
-
Retrophin to Present at Upcoming Investor Conferences
-
Retrophin to Present at Upcoming Investor Conferences
-
Kiniksa Pharmaceuticals (KNSA) IPO Opens 36% Higher

